Sunshine Act of 2022
This bill specifies that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
To amend title XI of the Social Security Act to clarify manufacturer 
  transparency reporting requirements for certain transfers used for 
                         educational purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Sunshine Act of 2022''.

SEC. 2. CLARIFYING MANUFACTURER TRANSPARENCY REPORTING REQUIREMENTS FOR 
              CERTAIN TRANSFERS USED FOR EDUCATIONAL PURPOSES.

    (a) In General.--Section 1128G(e)(10)(B)(iii) of the Social 
Security Act (42 U.S.C. 1320a-7h(e)(10)(B)(iii)) is amended by 
inserting ``, including peer-reviewed journals, journal reprints, 
journal supplements, medical conference reports, and medical 
textbooks'' after ``patient use''.
    (b) Effective Date.--The amendment made by this section shall apply 
with respect to transfers of value made on or after the date of the 
enactment of this Act.
                                 <all>
Sunshine Act of 2022
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
Sunshine Act of 2022
Rep. Burgess, Michael C.